The American College of Obstetricians and Gynecologists guidelines recommend systemic hormone replacement therapy with estrogen and progestogen for women with a uterus to mitigate endometrial cancer risk from estrogen-stimulated uterine lining growth, or estrogen alone without

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

Specific solid tumor cancer types organized by organ system and tissue origin.

Cancer treatment modalities including targeted therapy, immunotherapy, biologic therapies, and AI-driven treatment approaches.

Cancer prevention strategies, screening, early detection, and diagnostic approaches.